ArticlePloS one2012

t-10, c-12 CLA dietary supplementation inhibits atherosclerotic lesion development despite adverse cardiovascular and hepatic metabolic marker profiles.

Patricia L Mitchell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.